How to Structure Cannabis Deals for Success and Navigate Regulatory Challenges

Most cannabis deals don’t fail in negotiation—they fail in structuring. This blog breaks down how seemingly obvious considerations (ownership, real estate, and regulatory alignment) are sometimes overlooked, and ultimately determine whether your deal can close.

---

Most cannabis deals do not fail because of poor negotiation. Instead, they fail because of how they are structured. On paper, many transactions seem solid: parties agree on price, sign contracts, and appear aligned. But when it comes time to close, deals often stall or fall apart. The reason is that cannabis deals must survive regulatory review and operational realities, not just legal scrutiny.

In the cannabis industry, closing a deal is not just a legal event. It is a regulatory outcome. If your deal structure does not match how regulators evaluate ownership, control, and compliance, the deal will not close, no matter how well negotiated. This post explains the key areas where cannabis deals often fail and how to structure your deal to ensure it actually closes.

Ownership and Control Structuring

One of the biggest reasons cannabis deals fail is a mismatch between deal structure and regulatory expectations about ownership and control. Founders and investors often focus on equity percentages, but regulators look deeper. They want to know:

• Who has decision-making authority

• Who has economic influence

• Who can exert control through contracts or side agreements

  
  

Regulators examine not just who owns shares but who controls the business in practice. This includes looking at:

• Veto rights

• Management agreements

• Convertible instruments

• Side letters or informal arrangements

  
  

Common Mistakes

A frequent error is structuring deals with “hidden control” that is not clearly disclosed or does not align with regulatory rules. For example, a party might hold veto rights or management control without owning a majority of shares. If this control is not transparent, regulators may delay approval or reject the deal.

Business Impact

If regulators find an undisclosed or impermissible party controls the business, they can delay, deny, or force a restructuring of the deal mid-process. This can cause costly delays or even kill the deal entirely.

Example: A cannabis operator agreed to sell a majority stake to an investor. However, the investor retained veto rights over key decisions through a side letter not disclosed to regulators. When regulators discovered this, they delayed approval and required the deal to be restructured to remove the veto rights before closing.

Real Estate and Operational Alignment

In cannabis, real estate is more than a business asset. It is a regulatory requirement. A deal tied to a property that does not meet zoning, buffer, or local approval rules is often a dead deal.

Key Real Estate Issues

• Zoning and buffer compliance: Cannabis businesses must comply with local zoning laws and maintain required distances from schools, parks, and other sensitive areas.

• Local approvals and municipal restrictions: Some municipalities ban cannabis businesses or impose strict limits. Local approval is often required before state regulators will approve a license transfer or new license.

• Lease term and control: Leases must be long enough to satisfy regulators. Short-term or month-to-month leases raise red flags. Also, the lease must not give impermissible control to landlords.

  
  

Why This Matters

If a deal involves a property that is not compliant, regulators will not approve the license transfer or new license. This is not something that can be fixed late in the process. The deal will stall or fail.

Example: A cannabis operator tried to acquire a business with a lease on a property that was too close to a school. The local municipality denied approval, and the state regulator refused to transfer the license. The deal collapsed because the real estate was not aligned with regulatory requirements.

Regulatory Approvals and Timing

Regulatory approval is the final hurdle for cannabis deals. Even well-structured deals can fail if parties do not understand the timing and process.

What to Know About Regulatory Approvals

• Regulators review ownership, control, real estate, and compliance before approving transfers or new licenses.

• Approval timelines vary by state and can take months.

• Regulators may request additional information or require changes to deal terms.

• Some states require public notice or hearings, which can add complexity.

Bottom line: experienced counsel is often necessary to navigate approvals efficiently.

Managing Regulatory Risk

• Engage regulatory experts early to review deal structure.

• Disclose all control arrangements transparently.

• Confirm real estate compliance before signing.

• Build regulatory approval contingencies into deal agreements.

  
  
  
  

Practical Tips to Ensure Your Cannabis Deal Closes

1. Map out ownership and control clearly. Identify who has decision rights, economic influence, and control through contracts. Disclose everything to regulators.

2. Confirm real estate compliance early. Check zoning, buffers, lease terms, and local approvals before committing.

3. Work with cannabis regulatory counsel. Experienced lawyers can spot red flags and help structure deals to pass regulatory review.

4. Build flexibility into deal terms. Include contingencies for regulatory delays or required restructuring.

5. Communicate openly with regulators. Early engagement can prevent surprises and speed approvals.

   
   

Structuring cannabis deals requires more than legal negotiation skills. It demands a deep understanding of regulatory rules around ownership, control, real estate, and approvals. Deals that ignore these realities often fail to close, wasting time and money.